| Fonds | 2026/Q2 | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 18.499.547 $ | -25.120.805 $ | -57,6 % | 532.595.122 $ | +159.141.849 $ | +209,6 % | 333.443.074 $ | |||
| EQT Fund Management S.a r.l. | 113.332.263 $ | +28.936.946 $ | +34,3 % | 84.395.317 $ | |||||
| RA CAPITAL MANAGEMENT, L.P. | 80.341.728 $ | +21.127.586 $ | +35,7 % | 59.214.142 $ | |||||
| Pivotal bioVenture Partners Investment Advisor LLC | 44.300.420 $ | +11.311.156 $ | +34,3 % | 32.989.264 $ | |||||
| Andera Partners | 18.499.547 $ | -25.120.805 $ | -57,6 % | 43.620.352 $ | +11.137.515 $ | +34,3 % | 32.482.837 $ | ||
| RTW INVESTMENTS, LP | 34.536.383 $ | +12.559.935 $ | +57,2 % | 21.976.448 $ | |||||
| MPM BioImpact LLC | 33.470.290 $ | +31.535.353 $ | +1.629,8 % | ||||||
| Nan Fung Group Holdings Ltd | 33.129.326 $ | +8.458.858 $ | +34,3 % | 24.670.468 $ | |||||
| SymBiosis Capital Partners, LLC | 29.445.086 $ | +7.518.167 $ | +34,3 % | 21.926.919 $ | |||||
| EVENTIDE ASSET MANAGEMENT, LLC | 27.797.876 $ | +11.336.568 $ | +68,9 % | 16.461.308 $ | |||||
| JPMORGAN CHASE & CO | 22.408.385 $ | ||||||||
| Janus Henderson Group Ltd. | 20.615.133 $ | ||||||||
| MARSHALL WACE, LLP | 20.224.946 $ | +3.306.960 $ | +19,5 % | 16.917.986 $ | |||||
| BAKER BROS. ADVISORS LP | 19.481.496 $ | ||||||||
| Alyeska Investment Group, L.P. | 16.699.062 $ | ||||||||
| Defilade Capital Management, L.P. | 15.600.761 $ | +11.912.805 $ | +323,0 % | ||||||
| 18.499.547 $ | -25.120.805 $ | -57,6 % | 532.595.122 $ | +159.141.849 $ | +209,6 % | 333.443.074 $ | |||